Viewing nowCombinationEmpagliflozin/Metformin Tablet 5/850 mg
Empagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 202107473 · Approved 2021.11.15 · Insurance code 643309960
Improvement of glycemic control in adults with type 2 diabetes
This medication is used to improve blood sugar control in adult patients with type 2 diabetes when combined with dietary and exercise regimen. It is particularly suitable for patients who are not adequately controlling their blood sugar, and should be administered cautiously in patients with a history of cardiovascular events, considering the relevant clinical trial information. This medication helps effectively control blood sugar and improves the health of patients.
The recommended dose of this medicine is 1 tablet twice daily. Determine the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose in that case. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2)). Older adults In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is intended to help with blood sugar control; it may cause a dangerous condition called severe lactic acidosis, so caution is advised. If used in conjunction with other diabetes medications, hypoglycemia may occur, so precautions should be taken. Patients with severely impaired kidney function or those with acute infection, dehydration, or heart disease should not take this medication. It is not administered to pregnant or breastfeeding women, and patients with impaired liver function should also avoid it. This medication should be temporarily discontinued before and after surgery or before and after tests using iodinated contrast media. Kidney function should be regularly monitored during the use of this medication to ensure there are no abnormalities. Due to the risk of hypoglycemia, dose adjustments may be necessary when used with insulin or other hypoglycemic agents. Patients at risk of fluid loss, especially the elderly or those exhibiting dehydration, should be closely monitored. This medication may increase the risk of urinary or genital infections, so if related symptoms occur, consult a physician immediately. Vitamin B12 deficiency may occur, so it is advisable to check blood levels during long-term use. Excessive alcohol consumption should be avoided, and caution is also needed with sudden reductions in food intake or intense physical activities. If symptoms such as fever, pain, or swelling occur during the use of this medication, notify healthcare personnel immediately. Elderly patients face risks of impaired kidney function, so dosage adjustments and regular monitoring of their condition are necessary. In case of overdose, seek immediate medical attention for appropriate treatment, as blood dialysis may be required. This medication is not recommended for children, and those under 18 years of age should not take it.
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid areas that are too hot or too cold, storing it at room temperature between 1 and 30 degrees Celsius is recommended.
White film-coated tablet with a yellow tint, convex on both sides, oval-shaped
60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 31.38mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.